Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Aurora Cannabis

GrowGeneration Corp

SNDL Inc.

Tilray Brands

The so-called “Meme Stock” revolution is upon us. Retail investors and social media trading “gangs” are ganging up on institutional hedge fund shorts and bears with massive implications for the publicly traded stock market.

Is Cannabis the Next Meme Stock Trader Target? (SGMD, TLRY, CGC, SNDL, GRWG, ACB)

Amplify Seymour Cannabis ETF

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Innovative Industrial Properties

Amplify Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

Global X Cannabis ETF

Trulieve Cannabis Corp.

AXS Cannabis ETF

Cambria Cannabis ETF

AdvisorShares Vice ETF

AdvisorShares Pure Cannabis ETF 

Our first two Master Classes in cannabis investing with SA authors James Baker and Julian Lin were so successful we're coming back for #3! We discuss why retail cannabis investors are focused too much on near term catalysts and missing the long term picture.

Master Class In Cannabis Investing, Part 3 (Podcast)

Are These The Top Canadian Marijuana Stocks To Invest In ? The post Best Canadian Marijuana Stocks To Buy? 2 For Your Watchlist appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Best Canadian Marijuana Stocks To Buy? 2 For Your Watchlist

The company's CEO has set up some lofty expectations for the business that I'm not confident it will be able to deliver on.

Will This Colossal Mistake Send Canopy Growth Stock Crashing?

HEXO Corp

22nd Century Group

Two cannabis companies team up to explore new forms of cannabis consumption.

Why 22nd Century Group, HEXO, and Canopy Growth Stocks All Popped Today

Despite the recent significant pullback in CGC stock, there appears to be little potential for another up leg in Canopy Growth. The post The Green Gold Rush Is Over In Canopy Growth For Now appeared first on InvestorPlace.

The Green Gold Rush Is Over In Canopy Growth For Now

2 Marijuana Stocks To Watch For Better Trading In June The post Will These Marijuana Stocks Build More Momentum In June? appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Will These Marijuana Stocks Build More Momentum In June?

When Canadian rapper Drake announced he was partnering with cannabis giant Canopy Growth Corporation (TSX: WEED) (NYSE: CGC), the celebrity value seemed to be positive for both parties. Now, over a year since teaming up, Canopy and Drake have parted ways, reported The Canadian Press.

Canopy Growth & Rapper Drake Terminate Cannabis Collaboration, Cannabis Giant Still Has Martha Stewart

Applied DNA Sciences

Arena Pharmaceuticals

FSD Pharma

Neptune Wellness Solutions Inc.

OrganiGram Holdings Inc.

cbdMD Inc

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and look ahead to how the cannabis industry continues to take shape in 2021.

Breaking Down a Busy Week of Weed Stocks

Can investors count on this troubled marijuana producer to turn around?

Is Canopy Growth a Buy?

Tara Rozalowsky, vice president of beverages and edibles at Canopy Growth Corp (NASDAQ:CGC), discussed the latest developments on the CBD front at the Benzinga Cannabis Capital Conference on Thursday. The Pandemic And CBD: The COVID-19 pandemic helped catalyze what was already a growing demand for CBD products, Rozalowsky said.

Canopy Growth Exec: CBD Beverage Market Will Hit $1.5B In Coming Years

Cannabis-focused investment and acquisition company, RIV Capital Inc.  (TSX:RIV) (OTCQX: CNPOF) posted its latest financial earnings report on Thursday, touting a pop in total comprehensive income that hit CA$64.8 million ($53.7 million) in the fourth quarter of 2021.

Cannabis-Focused RIV Capital Reports Q4 And Fiscal Year 2021 Results, Closes Deal With Canopy Growth

Pandemic-related shutdowns could make things go from bad to worse for Canadian producers.

Why the Next Quarter Could Be Tough for Canadian Cannabis Companies

Marijuana legalization just won a powerful ally.

Why Canopy Growth, Aurora Cannabis, and Hexo Stocks Are on Fire Today

Cronos Group

The marijuana industry is now an exciting place for traditional investors. If you discover the legal grey areas of this space, it could mean big things for your portfolio.

Marijuana Stocks on the Move

Canopy Growth Corp. (CGC) CEO David Klein on Q4 2021 Results - Earnings Call Transcript

The earnings spotlight was on the cannabis sector  this morning, after Canopy Growth Corporation's (NASDAQ:CGC) mixed fiscal fourth-quarter report.

Canopy Growth Stock Crumbles After Quarterly Report

It's bad news all around in the marijuana industry today.

Why Canopy Growth Stock Crashed Today and Took OrganiGram and Cronos Down With It

Some states are dealing with pot shortages in 2021 that are making it hard for marijuana companies to keep up with demand. The post Pot Shortages 2021: 18 Things for Marijuana Stock Investors to Know appeared first on InvestorPlace.

Pot Shortages 2021: 18 Things for Marijuana Stock Investors to Know

Canopy Growth Corporation (TSX:WEED, NASDAQ:&nbsp, CGC)) reported Tuesday its fourth quarter and fiscal year 2021 earnings with a net loss for the year amounting to CA$1.7 billion ($1.41 billion), representing a CA$283 million wider loss versus FY 2020.  The Canadian cannabis giant attributed these results to various expenses, credit losses, lower income tax recoveries, advancements of gross margins, and sales reductions.

Canopy Growth's Shares Slide On Fiscal 2021 Billion Dollar Losses, Claims Its Still 'On Track To Achieving Positive Adjusted EBITDA'

Cloudera

Here's a quick look at a couple of earnings reports that were released before Tuesday's opening bell.

Earnings Hits and Misses: Canopy Growth, Cloudera

Canopy Growth Corp (TSE: WEED) said on Tuesday its revenue came in lower-than-expected in the fiscal fourth quarter. Its quarterly loss also printed high than what analysts had predicted.

3 key highlights from Canopy Growth's Q4 report

The company didn't hit analysts' estimates but continues to move in the right direction.

What's Behind Canopy Growth's Q4 Earnings Miss

News of impending legislation to legalize marijuana in the U.S. is encouraging, but investors in CGC stock have been hurt before. The post Be Careful About Buying the Spike in Canopy Growth appeared first on InvestorPlace.

Be Careful About Buying the Spike in Canopy Growth

The U.S.-listed shares of Canopy Growth Corp. rose 0.8% in premarket trading Tuesday, even after the Canada-based cannabis company reported a wider-than-expected fiscal fourth-quarter loss and revenue that rose less than forecast. The net loss for the quarter to March 31 narrowed to C$700.0 million ($581.5 million), or $1.85 a share, from loss of $1.30 billion, or $3.72 a share, in the same period a year ago.

Canopy Growth reports wider-than-expected loss, but stock gains

News for Canopy Growth Stock (CGC)